『Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial』（Lancet Oncol 2020;21:1224）より まとめ 小細胞肺が…